Morning Market Losers

Loading...
Loading...
Pain Therapeutics
PTIE
shares dipped 60.72% to $1.63 after Pfizer
PFE
announced that it will discontinue deal on REMOXY and Pain Therapeutics will regain full development and commercial rights to REMOXY. DURECT
DRRX
shares fell 43.88% to $0.78 after Pfizer discontinued deal on REMOXY. Akebia Therapeutics
AKBA
shares declined 35.90% to $12.64 after the company reported positive top-line results from its Phase 2b study of AKB-6548 in non-dialysis patients with anemia related to chronic kidney disease. Sarepta Therapeutics
SRPT
shares tumbled 34.55% to $15.42 on the FDA requirement of additional data from Sarepta on Eteplirsen. Precision Drilling
PDS
shares slipped 9.70% to $7.99. Precision Drilling reported a 79% gain in its third-quarter profit and lifted its quarterly dividend by 17%. Regulus Therapeutics
RGLS
shares slipped 8.14% to $15.92 after jumping 19.19% on Friday. Huntsman
HUN
shares declined 4.83% to $23.32. Huntsman reported upbeat earnings for the third quarter. GoPro
GPRO
shares dropped 4.64% to $68.58 after falling 9.15% on Friday.
Posted In: NewsMovers & ShakersIntraday UpdateMarketsmarket losersTop Losers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...